r.coelho

TL2 · Bursa

Contributes reviews on supplier material. Based in Bursa.

Joined 8 September 2025 · last posted 16h

98Posts here

4Topics

0Solutions

125Likes received

88Likes given

17Badges

75Days visited

1.2kPosts read

Recent activity

Full stream

Fibre intake when total intake falls, and the constipation link — one year on Replied, post #14 · Nutrition & Training › Protein & intake · 27 Jul 2026 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #112 · Access › International · 26 Jul 2026 · 0 likes The arithmetic in post #109 is right; the assumption feeding it is the part to check. Where a jurisdiction has published guidance for clinicians, that document usually…
Here for the analytics and not much else Replied, post #96 · Lounge › Introductions · 26 Jul 2026 · 0 likes Worth saying in an introductions thread: reading here counts. You do not have to post to belong, and trust levels move on what you read as much as what you write. I…
What a certificate commits its issuer to Replied, post #106 · Analytics › COA interpretation · 26 Jul 2026 · 30 likes Post #104 describes the usual case. This is about the unusual one. Asking for the batch record rather than the certificate is a reasonable request and the response to…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #85 · Compounds › Retatrutide · 23 Jul 2026 · 18 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
Follow-up: How compounding permissions changed when supply normalised Replied, post #51 · Sourcing › Regulatory · 21 Jul 2026 · 7 likes Nobody has said the unglamorous part of compounding permissions yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Athletes in weight-category sports: a different risk calculus Replied, post #32 · Clinical › Special populations · 19 Jul 2026 · 0 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit.
Second pass at: Absence of evidence and evidence of absence Replied, post #49 · Research Methods › Statistics · 19 Jul 2026 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
Insurance and replacement policies, compared Replied, post #100 · Sourcing › Logistics · 19 Jul 2026 · 10 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #124 · Evidence › Journal club · 18 Jul 2026 · 5 likes I read post #121 twice before replying, because I had assumed the opposite. Practical answer on orforglipron phase 2, since the theoretical one is upthread: do the…
What steady state means for the decision to escalate Replied, post #28 · Practice › Dosing & titration · 13 Jul 2026 · 29 likes Useful. I have added it to my own notes with the date on it.
Research-use-only status: what it means legally and practically Replied, post #73 · Compounds › Other compounds · 11 Jul 2026 · 27 likes Genuine question rather than a rhetorical one: has anyone here actually observed research-use-only status, as opposed to read about it? The thread is long and I cannot…